The goal of the Connors Center IGNITE Awards is to advance understanding of female-specific and sex-differentiated effects in novel therapeutics. IGNITE investigations leverage the Connors Center’s emerging First.in.Women Precision Medicine Platform to help shape the scientific focus of the study, to leverage Connors Center and FiW resources, and to assess project goals, milestones and deliverables to ensure that the emerging clinical translation remains aligned with the First.in.Women mission. IGNITE research includes basic, translational, and clinical research designed to advance therapeutic strategies using drugs, devices, and digital therapeutics.
The Connors Center supported four IGNITE awards during the 2019-2020 academic year which provided seed funding for early stage projects to advance the understanding of female-specific and sex-differentiated effects in novel therapeutics.
This year, we are pleased to announce a Special IGNITE award focused on sex- and gender-differences in cardiac and vascular diseases. This Special IGNITE award was established through the generous gift made by the Scott Schoen and Nancy Adams Research Fund in Women’s Vascular Disease.
Connors IGNITE Awards are funded by gifts from the annual Women’s Health Luncheon and by other generous donors.